Get the Stockscreener App
3.03
3.83%
-0.10
Dna X Inc stock is traded at $3.03, with a volume of 1,094.
It is down -3.83% in the last 24 hours and down -20.37% over the past month.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$3.13
Open:
$3.2113
24h Volume:
1,094
Relative Volume:
0.05
Market Cap:
$4.51M
Revenue:
$27.40M
Net Income/Loss:
$-17.12M
P/E Ratio:
-0.0283
EPS:
-106.8896
Net Cash Flow:
$-24.99M
1W Performance:
-8.26%
1M Performance:
-20.37%
6M Performance:
-31.12%
1Y Performance:
-71.66%
1-Day Range:
$3.03
$3.2113
1-Week Range:
$3.0292
$3.465
52-Week Range:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.03 | 4.66M | 27.40M | -17.12M | -24.99M | -106.89 |
MSFT
Microsoft Corp
|
492.85 | 3.67T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
162.10 | 468.13B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
170.23 | 409.24B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
209.35 | 215.05B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
157.42 | 115.54B | 7.11B | 1.95B | 2.44B | 2.5883 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
How DNA's Double Helix Structure Was Discovered - Britannica
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
Restriction-enzyme DNA fingerprinting method explained - Britannica
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesPost-Announcement Reaction - vinanet.vn
DNA X, Inc. announced that it has received $5.000004 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Synthetic Short - vinanet.vn
Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
7.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):